BridgeBio Pharma, Inc.
BBIO
$66.54
$2.013.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.75% | 142.54% | 69.04% | 4.02% | 56.62% |
| Total Receivables | 2,853.07% | 24,276.15% | 11,546.67% | -51.05% | 169.67% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 23.76% | 64.09% | 93.31% | 14.31% | 27.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 47.67% | -96.62% | -96.16% | 2,362.60% | -77.03% |
| Total Current Assets | 10.69% | 88.80% | 48.04% | -11.26% | 50.90% |
|
|
|||||
| Total Current Assets | 10.69% | 88.80% | 48.04% | -11.26% | 50.90% |
| Net Property, Plant & Equipment | 5.77% | -18.21% | -28.14% | -28.78% | -35.60% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 17.35% | 17.41% | 17.47% | 8.09% | -9.09% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -8.15% | 25.78% | -4.22% | -19.85% | -13.46% |
| Total Assets | 1.82% | 50.12% | 35.98% | 3.80% | 68.26% |
|
|
|||||
| Total Accounts Payable | 276.67% | 39.95% | 44.18% | 482.17% | -9.73% |
| Total Accrued Expenses | 92.11% | 75.28% | 44.11% | -5.69% | 6.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 37.42% | 15.09% | 3.44% | 14.63% | 9.16% |
| Total Finance Division Other Current Liabilities | -55.61% | -45.11% | -29.97% | -29.08% | 33.92% |
| Total Other Current Liabilities | -55.61% | -45.11% | -29.97% | -29.08% | 33.92% |
| Total Current Liabilities | 86.51% | 55.59% | 30.88% | 7.51% | 7.34% |
|
|
|||||
| Total Current Liabilities | 86.51% | 55.59% | 30.88% | 7.51% | 7.34% |
| Long-Term Debt | 7.62% | 7.66% | 7.68% | 7.70% | -0.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -18.85% | -41.25% | -42.98% | -40.76% | -47.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 74.90% | 4,372.41% | 4,652.79% | 2,414.81% | 5,203.62% |
| Total Liabilities | 26.74% | 55.09% | 52.34% | 33.62% | 25.84% |
|
|
|||||
| Common Stock & APIC | 8.12% | 7.58% | 7.01% | 6.45% | 28.50% |
| Retained Earnings | -23.41% | -28.15% | -29.09% | -25.73% | -20.92% |
| Treasury Stock & Other | -17.55% | -17.56% | -17.55% | -17.56% | -0.01% |
| Total Common Equity | -42.15% | -57.17% | -63.58% | -57.06% | -8.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -42.15% | -57.17% | -63.58% | -57.06% | -8.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -2.56% | -10.31% | -12.84% | -23.20% | -12.20% |
| Total Equity | -42.46% | -57.81% | -64.35% | -58.04% | -8.57% |
|
|
|||||